Article Text

PDF
New short-term heat inactivation method of cytomegalovirus (CMV) in breast milk: impact on CMV inactivation, CMV antibodies and enzyme activities
  1. Jens Maschmann1,2,
  2. Denise Müller3,
  3. Katrin Lazar3,
  4. Rangmar Goelz1,
  5. Klaus Hamprecht3
  1. 1Department of Neonatology, University Hospital of Tuebingen, Tuebingen, Germany
  2. 2University Hospital Jena, Jena, Germany
  3. 3Institute of Medical Virology and Epidemiology of Viral Diseases, University Hospital of Tuebingen, Tubingen, Germany
  1. Correspondence to Professor Klaus Hamprecht, Institute of Medical Virology and Epidemiology of Viral Diseases, University Hospital of Tuebingen, Tuebingen 72076, Germany; Klaus.Hamprecht{at}med.uni-tuebingen.de

Abstract

Objectives Breast milk (BM) is the primary source of cytomegalovirus (CMV) transmission to premature infants with potentially harmful consequences. We therefore wanted to evaluate temperature and duration of short-term BM pasteurisation with respect to CMV inactivation, effect on CMV-IgG antibodies and BM enzyme activities.

Methods 116 artificially CMV-spiked BM and 15 wild-type virus-infected samples were subjected for 5 s to different temperatures (55°C–72°C). CMV-IE-1 expression in fibroblast nuclei was assessed using the milk whey fraction in short-term microculture. BM lipase and alkaline phosphatase (AP) activities and CMV binding using CMV-recomLine immunoblotting and neutralising antibodies using epithelial target cells were analysed before and after heating.

Results A minimum of 5 s above 60°C was necessary for CMV inactivation in both CMV-AD-169 spiked and wild-type infected BM. Lipase was very heat sensitive (activities of 54% at 55°C, 5% at 60°C and 2% at 65°C). AP showed activities of 77%, 88% and 10%, respectively. CMV-p150 IgG antibodies were mostly preserved at 62°C for 5 s.

Conclusion Our results show that short-term pasteurisation of BM at 62°C for 5 s might be efficient for CMV inactivation and reduces loss of enzyme activities, as well as CMV binding, and functional CMV antibodies.

  • CMV
  • short term heat treatment
  • holder milk pasteurization
  • enzymes in breast milk
  • human milk CMV antibodies
  • CMV neutralization
View Full Text

Statistics from Altmetric.com

Footnotes

  • Patient consent for publication Not required.

  • Funding KL received a PhD grant from ‘Sonderlinie Medizin’ (University of Ulm, Freiburg, Tübingen).

  • Competing interests JM and KH are holding a patent on a method for short-term pasteurisation of human milk (Internat. Pat. Application WO 00/74494).

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.